Leukemia  >>  Decadron (dexamethasone)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT01900509: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Completed
1
16
US
Bendamustine, Treanda(R), Bendamustine hydrochloride, Clofarabine, Clolar(TM), Clofarex, Etoposide, VP-16, Vepesid(R), Etoposide phosphate, Etopophos(R), Dexamethasone, Decadron(R)
St. Jude Children's Research Hospital, Teva Pharmaceuticals USA
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Acute Leukemia
05/16
05/16
NCT02293109: Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma

Completed
1
10
US
carfilzomib, Kyprolis, PR-171, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, doxorubicin hydrochloride, ADM, ADR, Adria, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, leucovorin calcium, CF, CFR, LV, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, rituximab, IDEC-C2B8, IDEC-C2B8 monoclonal antibody, Mabthera, MOAB IDEC-C2B8, Rituxan, laboratory biomarker analysis
Mehrdad Abedi, MD, Amgen
Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia
12/17
01/18
NCT01363817: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Completed
1
31
Europe, US
BMS-906024, Notch inhibitor, Dexamethasone, Baycadron
Bristol-Myers Squibb
Lymphoblastic Leukemia, Acute T-cell, Precursor T-Cell Lymphoblastic Lymphoma
02/18
02/18
RELPALL, NCT03515200: Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia

Terminated
1
12
US
Palbociclib Oral Capsule, Ibrance®, Intrathecal Triple Therapy, ITMHA, methotrexate/hydrocortisone/cytarabine, Dexamethasone, Decadron, Bortezomib, Velcade®, Dasatinib, Sprycel®, Doxorubicin, Adriamycin®, Ruxolitinib, Jakafi®
St. Jude Children's Research Hospital, Pfizer
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission
07/20
07/20
NCT03349281: Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Completed
1
6
US
Pevonedistat, TAK-924, MLN4924, Vincristine, Oncovin, VCR, LCR, Dexamethasone, Decadron, Hexadrol, Dexone, Dexameth, PEG-asparaginase, Oncaspar, Pegaspargase, Polyethylene Glycol Conjugated L-asparaginase-H, Doxorubicin, Adriamycin, Cytarabine, ARA-C, Methotrexate, MTX, Amethopterin, Hydrocortisone, Cortisol
Julio Barredo, MD, Takeda
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
08/21
10/22
NCT05016947: Venetoclax Plus Inotuzumab for B-ALL

Recruiting
1
26
US
Venetoclax, Venclexta, Dexamethasone, Decadron, Dexasone, Diodex, Hexadrol, Maxidex, Inotuzumab Ozogamicin, Besponsa
Dana-Farber Cancer Institute, AbbVie
B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL
07/24
06/26

Download Options